Cargando…
Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway
BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory disorder of the colon and rectum, which is positively correlated with the occurrence of IBD-related colorectal cancer (IBD-CRC). Conventional therapies based on drugs such as corticosteroids, mesalamine, and immunosuppression have serious...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285600/ https://www.ncbi.nlm.nih.gov/pubmed/32517784 http://dx.doi.org/10.1186/s12906-020-02974-9 |
_version_ | 1783544733961814016 |
---|---|
author | Huangfu, Shaohua Dou, Renjie Zhong, Sixia Guo, Mengjie Gu, Chunyan Jurczyszyn, Artur Yang, Ye Jiang, Bin |
author_facet | Huangfu, Shaohua Dou, Renjie Zhong, Sixia Guo, Mengjie Gu, Chunyan Jurczyszyn, Artur Yang, Ye Jiang, Bin |
author_sort | Huangfu, Shaohua |
collection | PubMed |
description | BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory disorder of the colon and rectum, which is positively correlated with the occurrence of IBD-related colorectal cancer (IBD-CRC). Conventional therapies based on drugs such as corticosteroids, mesalamine, and immunosuppression have serious side effects. Pulsatillae decoction (PD) served as a classical prescription for the treatment of colitis in China, has been shown to exert prominent curative effects and good safety. Based on clinical experience and our amelioration, we added an extra herb into this classical prescription, but its therapeutic effect on UC and the underlying mechanism are still unclear. RESULTS: We first found the curative effect of modified PD on dextran sodium sulfate (DSS)-incubated NCM460 cells. Then C57BL/6 mice were administered DSS to induce UC to evaluate the therapeutic of modified PD. The results showed that modified PD alleviated the inflammatory injury, manifested in body weight, colon length, and disease activity index, with histological analysis of colon injury. Transcriptomic sequencing indicated that modified PD treatment downregulated the IL-6/STAT3 signaling pathway, and reduced the levels of p-NF-κB, IL-1β and NLRP3, which were confirmed by western blot. CONCLUSIONS: Collectively, our results indict that modified PD could efficiently relieve clinical signs and inflammatory mediators of UC, providing evidence of the anti-colitis effect of modified PD, which might provide novel strategies for therapeutic intervention in UC, which may be applied to the prevention of IBD-CRC. |
format | Online Article Text |
id | pubmed-7285600 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72856002020-06-10 Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway Huangfu, Shaohua Dou, Renjie Zhong, Sixia Guo, Mengjie Gu, Chunyan Jurczyszyn, Artur Yang, Ye Jiang, Bin BMC Complement Med Ther Research Article BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory disorder of the colon and rectum, which is positively correlated with the occurrence of IBD-related colorectal cancer (IBD-CRC). Conventional therapies based on drugs such as corticosteroids, mesalamine, and immunosuppression have serious side effects. Pulsatillae decoction (PD) served as a classical prescription for the treatment of colitis in China, has been shown to exert prominent curative effects and good safety. Based on clinical experience and our amelioration, we added an extra herb into this classical prescription, but its therapeutic effect on UC and the underlying mechanism are still unclear. RESULTS: We first found the curative effect of modified PD on dextran sodium sulfate (DSS)-incubated NCM460 cells. Then C57BL/6 mice were administered DSS to induce UC to evaluate the therapeutic of modified PD. The results showed that modified PD alleviated the inflammatory injury, manifested in body weight, colon length, and disease activity index, with histological analysis of colon injury. Transcriptomic sequencing indicated that modified PD treatment downregulated the IL-6/STAT3 signaling pathway, and reduced the levels of p-NF-κB, IL-1β and NLRP3, which were confirmed by western blot. CONCLUSIONS: Collectively, our results indict that modified PD could efficiently relieve clinical signs and inflammatory mediators of UC, providing evidence of the anti-colitis effect of modified PD, which might provide novel strategies for therapeutic intervention in UC, which may be applied to the prevention of IBD-CRC. BioMed Central 2020-06-09 /pmc/articles/PMC7285600/ /pubmed/32517784 http://dx.doi.org/10.1186/s12906-020-02974-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Huangfu, Shaohua Dou, Renjie Zhong, Sixia Guo, Mengjie Gu, Chunyan Jurczyszyn, Artur Yang, Ye Jiang, Bin Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway |
title | Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway |
title_full | Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway |
title_fullStr | Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway |
title_full_unstemmed | Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway |
title_short | Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway |
title_sort | modified pulsatillae decoction inhibits dss-induced ulcerative colitis in vitro and in vivo via il-6/stat3 pathway |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285600/ https://www.ncbi.nlm.nih.gov/pubmed/32517784 http://dx.doi.org/10.1186/s12906-020-02974-9 |
work_keys_str_mv | AT huangfushaohua modifiedpulsatillaedecoctioninhibitsdssinducedulcerativecolitisinvitroandinvivoviail6stat3pathway AT dourenjie modifiedpulsatillaedecoctioninhibitsdssinducedulcerativecolitisinvitroandinvivoviail6stat3pathway AT zhongsixia modifiedpulsatillaedecoctioninhibitsdssinducedulcerativecolitisinvitroandinvivoviail6stat3pathway AT guomengjie modifiedpulsatillaedecoctioninhibitsdssinducedulcerativecolitisinvitroandinvivoviail6stat3pathway AT guchunyan modifiedpulsatillaedecoctioninhibitsdssinducedulcerativecolitisinvitroandinvivoviail6stat3pathway AT jurczyszynartur modifiedpulsatillaedecoctioninhibitsdssinducedulcerativecolitisinvitroandinvivoviail6stat3pathway AT yangye modifiedpulsatillaedecoctioninhibitsdssinducedulcerativecolitisinvitroandinvivoviail6stat3pathway AT jiangbin modifiedpulsatillaedecoctioninhibitsdssinducedulcerativecolitisinvitroandinvivoviail6stat3pathway |